We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.39%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
426
CALL
DELISTED
Twitter, Inc.
TWTR
$1.38M 0.04%
+22,900
New +$1.5M
SKIN icon
427
SkinHealth Systems
SKIN
$85.7M
$1.38M 0.04%
+53,043
New +$1.17M
IHRT icon
428
iHeartMedia
IHRT
$583M
$1.37M 0.04%
54,784
+284
+0.5% +$7K
PBR icon
429
CALL
Petrobras
PBR
$116B
$1.37M 0.04%
132,500
+2,500
+2% +$26.6K
DG icon
430
Dollar General
DG
$27.9B
$1.36M 0.03%
6,412
+5,302
+478% +$1.2M
GSM icon
431
FerroAtlántica
GSM
$839M
$1.36M 0.03%
156,152
+12,978
+9% +$88.4K
FCX icon
432
Freeport-McMoran
FCX
$97.5B
$1.36M 0.03%
41,690
-44,269
-52% -$1.56M
PBR icon
433
PUT
Petrobras
PBR
$116B
$1.36M 0.03%
131,100
-29,500
-18% -$314K
ASTH icon
434
Astrana Health
ASTH
$1.77B
$1.35M 0.03%
+14,873
New +$1.26M
EHC icon
435
Encompass Health
EHC
$12.4B
$1.34M 0.03%
22,427
-6,573
-23% -$414K
GSM icon
436
CALL
FerroAtlántica
GSM
$839M
$1.34M 0.03%
153,800
-108,700
-41% -$741K
ACMR icon
437
ACM Research
ACMR
$5.79B
$1.34M 0.03%
+36,465
New +$1.12M
GOOGL icon
438
CALL
Alphabet (Google) Class A
GOOGL
$4.33T
$1.34M 0.03%
+10,000
New +$1.36M
RIO icon
439
CALL
Rio Tinto
RIO
$164B
$1.34M 0.03%
20,000
TGTX icon
440
PUT
TG Therapeutics
TGTX
$7.62B
$1.33M 0.03%
+40,000
New +$1.24M
ZEN
441
DELISTED
ZENDESK INC
ZEN
$1.32M 0.03%
11,334
-5
-0% -$646
FCX icon
442
PUT
Freeport-McMoran
FCX
$97.5B
$1.31M 0.03%
+40,400
New +$1.42M
FMNB icon
443
Farmers National Banc Corp
FMNB
$930M
$1.31M 0.03%
83,422
MOS icon
444
The Mosaic Company
MOS
$7.33B
$1.31M 0.03%
36,580
+21,021
+135% +$672K
IEF icon
445
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$1.3M 0.03%
11,300
-400
-3% -$46.8K
CUBI icon
446
Customers Bancorp
CUBI
$2.77B
$1.3M 0.03%
30,232
-704
-2% -$27.4K
SIVB
447
DELISTED
SVB Financial Group
SIVB
$1.3M 0.03%
2,009
+1,392
+226% +$807K
TGTX icon
448
TG Therapeutics
TGTX
$7.62B
$1.3M 0.03%
+38,982
New +$1.21M
EQIX icon
449
Equinix
EQIX
$103B
$1.29M 0.03%
1,636
-878
-35% -$729K
VXX icon
450
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
$1.29M 0.03%
+2,895
New +$1.3M

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.